HB 153 — AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.
Last action — to Health Services (H)
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill is in committee in the House. Introduced January 07, 2026. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the House.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
In Committee
Current position in the legislative process.
-
12 sponsors
12 primary, 0 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (6 D · 6 R) — cross-party backing.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
Bill Text
- Introduced View text Current pdf
Action History
-
to Health Services (H)
-
to Committee on Committees (H)
-
introduced in House
Sponsors
- Sarah Stalker · Primary
- Rachel Roarx · Primary
- Jason Nemes · Primary
- Kimberly Poore Moser · Primary
- Chris Lewis · Primary
- Vanessa Grossl · Primary
- Daniel Grossberg · Primary
- Ken Fleming · Primary
- Beverly Chester-Burton · Primary
- Steve Bratcher · Primary
- Chad Aull · Primary
- Lisa Willner · Primary
Sponsorship breakdown
Export CSV (upgrade) →12 sponsors · 0 co-sponsors · 126 not signed on
Sponsors (12)
- Sarah Stalker Democrat
- Rachel Roarx Democrat
- Jason Nemes Republican
- Kimberly Poore Moser Republican
- Chris Lewis Republican
- Vanessa Grossl Republican
- Daniel Grossberg Democrat
- Ken Fleming Republican
- Beverly Chester-Burton Democrat
- Steve Bratcher Republican
- Chad Aull Democrat
- Lisa Willner Democrat
Co-sponsors (0)
None.
Not signed on (126)
126 members have not signed on to this bill.
Show all 126 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 153 do?
- Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
- Who sponsors HB 153?
- HB 153 is sponsored by Sarah Stalker (Democrat), Rachel Roarx (Democrat), Jason Nemes (Republican), Kimberly Poore Moser (Republican), Chris Lewis (Republican), Vanessa Grossl (Republican), Daniel Grossberg (Democrat), Ken Fleming (Republican), Beverly Chester-Burton (Democrat), Steve Bratcher (Republican), Chad Aull (Democrat), and Lisa Willner (Democrat).
- What is the current status of HB 153?
- This bill is in committee in the House. Introduced January 07, 2026. It must pass committee before a floor vote.
- Where can I track HB 153?
- Track HB 153 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 153
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 153
Last checked for changes about 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →